Literature DB >> 8248381

Visual dysfunction in the spontaneously hypertensive rat.

L J Rogers1, S W Bolden, A S Patrech, D Ehrlich.   

Abstract

We report two forms of visual defect in the spontaneously hypertensive rat (SHR) compared to its normotensive control strain (WKY). Ten-month-old male SHR and WKY were tested for intensity discrimination ability using a Y-maze and food reward. The SHR took more trials in the acquisition phase of the task using white light. In the test phase, in which the white light intensity difference was reduced, there was no significant difference in performance between SHR and WKY. Also, there was no significant difference between the strains when red light was used. The defect in SHR occurred in the blue range of the spectrum. Using blue light, the performance of SHR declined significantly at an intensity difference of 1.15 lux, whereas the performance of WKY did not decline significantly until the difference reached 0.01 lux. The defect in SHR for intensity discrimination was not related to cataract formation, but we detected a strain difference in the nuclei of the photoreceptor cells. Thus, this visual dysfunction may involve the rod photoreceptors. Further testing revealed a deficit in visual acuity in SHR aged 40-66 days, prior to the development of hypertension. Thus, the visual dysfunction of SHR is not secondary to their development of hypertension, but rather a discrete characteristic of the strain.

Entities:  

Mesh:

Year:  1993        PMID: 8248381     DOI: 10.1016/0031-9384(93)90300-5

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  3 in total

1.  Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats.

Authors:  P Sicard; N Acar; S Grégoire; B Lauzier; A M Bron; C Creuzot-Garcher; L Bretillon; C Vergely; L Rochette
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

2.  Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.

Authors:  Roxann C Harvey; Chloe J Jordan; David H Tassin; Kayla R Moody; Linda P Dwoskin; Kathleen M Kantak
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

3.  CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents.

Authors:  Marianne Houssier; William Raoul; Sophie Lavalette; Nicole Keller; Xavier Guillonneau; Barbara Baragatti; Laurent Jonet; Jean-Claude Jeanny; Francine Behar-Cohen; Flavio Coceani; Daniel Scherman; Pierre Lachapelle; Huy Ong; Sylvain Chemtob; Florian Sennlaub
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.